Close Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Close Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.38M	Sell	105,158 -3,040	-3%	-$177K	0.17%	48
2025 Q4	$5.84M	Sell	108,198 -2,845	-3%	-$137K	0.13%	56
2025 Q3	$5.01M	Sell	111,043 -9,003	-7%	-$420K	0.11%	56
2025 Q2	$5.56M	Sell	120,046 -8,910	-7%	-$437K	0.16%	50
2025 Q1	$7.87M	Sell	128,956 -37,250	-22%	-$2.17M	0.23%	42
2024 Q4	$9.41M	Hold	166,206	–	–	0.26%	43
2024 Q3	$8.6M	Sell	166,206 -3,606	-2%	-$169K	0.26%	42
2024 Q2	$7.05M	Sell	169,812 -21,747	-11%	-$973K	0.24%	44
2024 Q1	$10.4M	Sell	191,559 -66,775	-26%	-$3.4M	0.38%	40
2023 Q4	$13.3M	Sell	258,334 -50,478	-16%	-$2.65M	0.55%	33
2023 Q3	$17.9M	Sell	308,812 -1,006	-0.3%	-$61.6K	0.93%	28
2023 Q2	$19.8M	Buy	309,818 +18,080	+6%	+$1.21M	0.93%	30
2023 Q1	$20.2M	Buy	291,738 +16,510	+6%	+$1.16M	1%	27
2022 Q4	$19.8M	Buy	275,228 +16,258	+6%	+$1.23M	1.05%	22
2022 Q3	$18.4M	Buy	258,970 +5,821	+2%	+$422K	1.04%	22
2022 Q2	$19.5M	Sell	253,149 -25,166	-9%	-$1.92M	0.92%	25
2022 Q1	$17.4M	Hold	278,315	–	–	0.62%	23
2021 Q4	$17.4M	Buy	278,315 +3,723	+1%	+$218K	0.62%	23
2021 Q3	$16.2M	Buy	274,592 +10,288	+4%	+$678K	0.79%	19
2021 Q2	$17.7M	Buy	264,304 +6,906	+3%	+$450K	0.84%	19
2021 Q1	$16.3M	Buy	+257,398	New	+$16M	0.86%	19
2019 Q2	–	Sell	-768	Closed	-$37K	–	178
2019 Q1	$37K	Buy	+768	New	+$38.3K	﹤0.01%	139
2018 Q3	–	Sell	-200	Closed	-$12K	–	220
2018 Q2	$12K	Hold	200	–	–	﹤0.01%	164
2018 Q1	$12K	Buy	+200	New	+$12.9K	﹤0.01%	171

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Close Asset Management's BMY Position: Q1 2026 in Review

Close Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q1 2026, selling an estimated $177K and leaving 105,158 shares worth $6.38M. The position accounts for 0.17% of the portfolio, ranked #48.

Close Asset Management first reported a position in BMY in Q1 2018 and has held it in 24 quarters since. The position peaked at $20.2M in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Close Asset Management held 105,158 shares of Bristol-Myers Squibb worth $6.38M as of Q1 2026.
Close Asset Management sold 3,040 Bristol-Myers Squibb shares in Q1 2026, an estimated $177K.
Bristol-Myers Squibb made up 0.17% of Close Asset Management's portfolio in Q1 2026, its #48 holding.
Close Asset Management first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 24 quarters since.
Close Asset Management's Bristol-Myers Squibb position peaked at $20.2M in Q1 2023.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.